the reaction to pH 7.5, and the first reaction cannot be highly buffered. The pH of the first reaction mixture was 5.00. The pH of the final reaction mixture was 7.10 for the test, 7.21 for the blank.
The aqueous solubility and ionization properties of drugs vary enormously, as reflected by the many procedures described for extracting drugs from urine. In routine clinical toxicology, however, it is highly desirable to minimize the number of procedures so as to extract efficiently as many drugs as possible with a given procedure. With this in mind, we have developed a urine-extraction scheme in which only two procedures based on one solvent system are used to extract a wide variety of drugs. A preliminary version of this method was presented recently (1). The alkaline procedure has proven suitable for basic, neutral, and weakly acidic drugs, whereas carboxylate drugs are extracted with the acidic extraction procedure.
Materials
Reagent-grade acetic anhydride was obtained from J.T Baker Chemical Co., Phillipsburg The fluorescence polarization (TDx) analyzer and accompanying supplies were obtained from Abbott Laboratories Ltd., Mississauga, Ontario. The gas chromatograph/mass spectrometer (GC/MS) system was purchased from Hewlett-Packard Canada Limited, Mississauga.
Ontario. The system consisted of a Hewlett-Packard (H-P) Model 5880 gas chromatograph interfaced with an H-P Mass Selective Detector Model 5970, which was equipped with a work station consisting of an H-P 9825 computer with an H-P Model 9134A Winchester 5 megabyte disk drive and an H-P Model 2671 thermal printer.
Methods
Sample preparation: We used 5 mmol/L stock solutions of each drug in acidified methanol (80 p.L of concentrated HC1 per 10 mL of absolute methanol), except as follows. The concentration of the methanolic phencycidine stock solution was 400 .Lmo1fL. Valproate and salicylate 5 mmolfL stock solutions were prepared in 100 mmol/L NaOH. The salicylate resulted when the acetylsalicylate was hydrolyzed in basic solution. A TDx calibrator solution served as the stock solution (17.3 pmol/L) for the benzoylecgonine experiments.
Samples of most drugs were prepared for the extraction study by supplementing 2-mL aliquots of drug-free urine with an aliquot of drug so that the final drug concentration was within the measurable range of the TDx analyzer. For experiments on benzoylecgonine we used TDx calibrator solutions appropriately diluted with a blank calibrator from the same lot.
We prepared aqueous stock solutions of acetaminophen acetate, morphine acetate, and nortriptyline acetate, using a scaled-up version of the acetylation procedure described below.
Extraction procedure: The urine sample was first acetylated under aqueous conditions (2) as follows. Add 400 mg of sodium bicarbonate to a 20 x 150 mm screw-capped culture tube containing 2 mL of urine and vortex-mix briefly. Add 200 pL of acetic anhydride but do not mix, and allow the sample to stand for 10 to 15 mm to acetylate. Vortex-mix, then add 20-SO mg of sodium bicarbonate to ensure that all of the acetic acid is neutralized (no further CO2 evolution). Add 2.5 mL of water to the tube, followed by a saturating amount of solid NaCI (about 4 g), and vortex-mix thoroughly. Add 5 mL of dichloromethane/ acetone (2:1 by vol) and invert the mixture 10 times. Set the sample aside for a few minutes to allow partial phase separation, then centrifuge (2000 x g, 10 mm). Aspirate the organic (top) phase, transfer it to a 15 x 85 mm tube, and evaporate it in a sand bath at 40#{176}C under a stream of nitrogen. Redissolve the residue in a suitable solvent for analysis by gas chromatography/mass spectrometry (CC! MS) or, if desired, further derivatize before analysis.
To extract drugs containing carboxyl groups, first adjust the 2-mL urine sample to pH 2 by adding 2 mL of 100 mmol/L Na2HPO4 and 0.1 mL of 1.63 molfL H2S04. Then saturate the sample with NaC1 and extract with dichloromethane/acetone as above. The carboxylate drugs in the dry extract can then be derivatized (e.g., silylated) before GCIMS analysis.
Analytical recovery: Dried extracts of drugs, obtained as described above, were recombined with 2 mL of urine, vortex-mixed, and analyzed in the TDx analyzer. Each drug studied was extracted and analyzed individually rather than in combination with other drugs, to avoid the possibility of cross-reactivity during the immunoanalysis. The recovery controls consisted of a sample obtained by (a) adding the aliquot from the drug stock solution directly to 2 mL of urine or (b) by adding the aiquot from the drug stock solution to an empty tube, evaporating, and then adding the 2 mL of urine to the residue. These two types of controls gave the same results. A control for investigating the effects of acetylation on the recovery of non-acetylatable drugs was performed by alkalunizing the urine with NaHCO3, and extracting the drug, omitting the acetylation step.
We studied the effect of acetylation on nortriptyine extraction efficiency by using nortriptyline acetate in the recovery control samples, because the data for nortriptyline and its acetate would not be directly comparable because of partial (rather than 100%) cross-reactivity in the immunoassay and because the acetate of an amine cannot be readily hydrolyzed. With samples containing morphine and acetaminophen, on the other hand, the acetate solution obtained when the extract was reconstituted in 2 mL of urine was hydrolyzed by alkalinizing with NaOH, then neutralized and analyzed. Samples containing underivatized morphine or acetaminophen were carried through the same procedure, except that the acetylation step was omitted.
All extraction and control samples were processed in duplicate or triplicate, and each sample was measured in the TDx analyzer, in duplicate.
Gas chromatography/mass spectrometry: We used splitless injection into a 30 m x 0.25mm (i.d.) column of SPB-5 fused silica (0.25 film thickness; Supelco Canada Ltd., Oakville, Ontario). The injection port temperature was 250 #{176}C, the inlet pressure was 70 kPa, and the purge time was 2 min. The oven was maintained at an initial temperature of 50 #{176}C for 0.5 mm, then programmed at 30 #{176}C!min to 140 #{176}C, 15 #{176}C!min to 210 #{176}C, 5 #{176}C/min to 300#{176}C, and finally 2 #{176}C/min to 320 #{176}C, when the run was terminated.
Retention times of most drugs and their metabolites ranged from 5 to 25 mm.
The mass spectrometer was operated with the ion source at 200-250 #{176}C and an electron energy of 70 eV. The electron multiplier of the detector was typically set at 2200 V. The capillary direct interface temperature was 250 #{176}C. Scanning (42-650 atomic mass units) began 3 mm after sample injection and continued to the end of the run.
Results and DIscussion
The drugs we used, which vary widely in polarity and ionization properties because of the variety of functional groups, included amines, amides, alcohols, phenols, carboxylic acids, and combinations thereof. Because most of these drugs usually are analyzed in the TDx in a serum matrix, we assessed the linearity of TDx response to these drugs in a urine matrix. The response of the instrument to all except amitriptyline and nortriptyline was linearly related to concentration, and the plotted line passed through the origin. Amitriptyline and nortriptyline results were linear
Second extraction with solvent system Increased recovery to 84.1% (SD 8.7% (n = 7)).
through y-intercepts of 55 and 45 nmol/L, respectively. Therefore we made appropriate corrections for these two drugs when calculating recoveries.
In the recovery studies, the acetaminophen and morphine acetates were hydrolyzed back to the original drug before measurement in the TDx (hydrolysis of these phenol acetates was extremely rapid in the presence of sodium hydroxide). The solution was then neutralized before analysis by TDx. Arnide bonds are very resistant to hydrolysis, so nortriptyline acetate was analyzed as such. Fortunately, the cross-reactivity of the tricyclic drug immunoassay is very broad, and measurement of nortriptyline acetate was no problem. On the other hand, amphetamine acetate could not be analyzed because the extremely specific fluorescence polarization immunoassay for amphetamine showed only very slight cross-reactivity for the acetate. Thus measurement of amphetamine recoveries was not possible. Tables 1  and 2 show that all drugs analyzed, except theophyffine and benzoylecgomne, were extracted from urine with at least 70% efficiency with only one volume of dichloromethane/acetone (2:1 by vol). Both theophylline and benzoylecgomne, however, are partly water soluble; thus their rather poor recoveries are not surprising. Recoveries nonetheless can be improved substantially, if desired, by doing a second extraction-something we have never found necessary for successful CC/MS confirmation of positive immunoassay screen results.
Our acetylation
procedure is a modification of the method of Martin and Baker (2) in which we added all of the NaHCO3 in one portion before adding the acetic anhydride (instead of adding the Na}1C03 a bit at a time after the acetic anhydride had been added). The method thus is much less labor intensive. The solid NaHCO3 settles to the bottom of the tube, and the acetic anhydride floats on the surface. Each reagent diffuses into the aqueous phase. The acetic acid, released as the acetylation reaction proceeds, reacts continuously with the NaHCO3 with a steady controlled evolution of CO2.
Martin and Baker reported that the acetate of the compound they studied, 2-phenylethylamine, which is a closely related analog of amphetamine and methamphetamine, was insufficiently volatile to be lost during solvent evaporation (2) . Similarly, we have not had noticeable evapora- tive losses of the acetates of otherwise volatile drugs. Consistent with this effect is the significant increase in retention time indices of these drugs upon acetylation (3).
The aqueous acetylation procedure forms acetates with phenolic hydroxyl groups and primary and secondary amino groups. Our preliminary experiments with nortriptyline, acetaminophen, dextroamphetamine, and morphine-with use of both Toxi-Lab thin-layer chromatography and CC/MS-showed that acetylation was quantitative, with complete disappearance of the underivatized drugs and appearance of the corresponding acetates. Details of these experiments are available upon request to interested readers.
Saturation with NaC1 performed several functions. It improved drug extraction via its well-known "salting-out" effect (4). The recovery of benzoylecgonine, for example, was 3 1.7% from NaC1-saturated solutions after one extraction, but without NaC1 addition it was only 5%. NaC1 saturation contributed to a usually very sharp interface, and the aqueous phase was made denser than the dichloromethane-acetone (upper) phase. This facilitated aspiration of the extract.
The dichloromethane-acetone phase appears to be quite anhydrous, and this, combined with the high volatility of both solvents, permits rapid (10-15 mm) evaporation of the solvents. This solvent system is also aprotic, so that any traces remaining after evaporation will not interfere with subsequent derivatizations (e.g., carboxylate silylation). The vast majority of drugs that are identified in a clinical Mean percent recovery, SD (and n) Interference by endogenous peaks has not been a problem. We have used this extraction scheme with our CC/MS confirmation analyses for more than three years and have built an in-house mass-spectrum library of over 300 drugs and their metabolites, endogenous compounds, and potential contaminants.
This system has proven particularly useful in the detection and identification of volatile basic drugs such as phenylpropanolarnine, the amphetamines (Figure 2) , and others, which under these conditions chromatograph well and are easy to identify as their acetates (3). Their mass spectra are not dominated by a single fragment ion (e.g., 44 and 58 mle), which occurs when these drugs are analyzed underivatized, requiring the analyst to identify them primarily on the basis of CC retention times (5) . Tricycic antidepressant metabolite acetates also have distinctive, easily identified mass spectra (3). This figure demonstrates the ease with which these volatile drugs are detected and separated, for subsequent identification according to their respective mass spectra.
In one of the most comprehensive readily available mass spectral databases of drugs and their metabolites (3, now also available on disk from Hewlett-Packard as an on-line CC/MS library), extensive use is made of acetate derivatives, as in our method. This greatly facilitates identification of drug metabolites for which no standards are available.
